{"created":"2023-05-15T15:12:38.594636+00:00","id":509,"links":{},"metadata":{"_buckets":{"deposit":"985d7404-8349-4535-a909-02ba874be5c5"},"_deposit":{"created_by":19,"id":"509","owners":[19],"pid":{"revision_id":0,"type":"depid","value":"509"},"status":"published"},"_oai":{"id":"oai:ompu.repo.nii.ac.jp:00000509","sets":["2:104:108:105"]},"author_link":["1613"],"control_number":"509","item_10006_alternative_title_1":{"attribute_name":"その他（別言語等）のタイトル","attribute_value_mlt":[{"subitem_alternative_title":"（前立腺がんにおいて、RB1欠失はRNASEH2B欠失によるPARP阻害剤感受性を無効化する）"}]},"item_10006_date_granted_11":{"attribute_name":"学位授与年月日","attribute_value_mlt":[{"subitem_dategranted":"2023-03-01"}]},"item_10006_degree_grantor_9":{"attribute_name":"学位授与機関","attribute_value_mlt":[{"subitem_degreegrantor":[{"subitem_degreegrantor_name":"大阪医科薬科大学"}],"subitem_degreegrantor_identifier":[{"subitem_degreegrantor_identifier_name":"34401","subitem_degreegrantor_identifier_scheme":"kakenhi"}]}]},"item_10006_degree_name_8":{"attribute_name":"学位名","attribute_value_mlt":[{"subitem_degreename":"博士（医学）"}]},"item_10006_description_10":{"attribute_name":"学位授与年度","attribute_value_mlt":[{"subitem_description":"2022","subitem_description_type":"Other"}]},"item_10006_dissertation_number_12":{"attribute_name":"学位授与番号","attribute_value_mlt":[{"subitem_dissertationnumber":"乙博医第18号"}]},"item_10006_identifier_registration":{"attribute_name":"ID登録","attribute_value_mlt":[{"subitem_identifier_reg_text":"10.57371/0000000509","subitem_identifier_reg_type":"JaLC"}]},"item_10006_link_22":{"attribute_name":"DOI","attribute_value_mlt":[{"subitem_link_url":"https://www.science.org/doi/10.1126/sciadv.abl9794"}]},"item_10006_version_type_18":{"attribute_name":"著者版フラグ","attribute_value_mlt":[{"subitem_version_resource":"http://purl.org/coar/version/c_970fb48d4fbd8a85","subitem_version_type":"VoR"}]},"item_access_right":{"attribute_name":"アクセス権","attribute_value_mlt":[{"subitem_access_right":"open access","subitem_access_right_uri":"http://purl.org/coar/access_right/c_abf2"}]},"item_creator":{"attribute_name":"著者","attribute_type":"creator","attribute_value_mlt":[{"creatorAffiliations":[{"affiliationNames":[{"affiliationNameLang":"ja"}]}],"creatorNames":[{"creatorName":"辻野, 拓也","creatorNameLang":"ja"},{"creatorName":"ツジノ, タクヤ","creatorNameLang":"ja-Kana"}],"nameIdentifiers":[{"nameIdentifier":"1613","nameIdentifierScheme":"WEKO"}]}]},"item_files":{"attribute_name":"ファイル情報","attribute_type":"file","attribute_value_mlt":[{"accessrole":"open_date","date":[{"dateType":"Available","dateValue":"2023-04-14"}],"displaytype":"simple","filename":"2022-os-018_主論文（辻野拓也）.pdf","filesize":[{"value":"29.8 MB"}],"format":"application/pdf","licensetype":"license_note","mimetype":"application/pdf","url":{"label":"主論文","url":"https://ompu.repo.nii.ac.jp/record/509/files/2022-os-018_主論文（辻野拓也）.pdf"},"version_id":"ec21f0fc-78c3-4c55-a4bc-9b57e0375486"},{"accessrole":"open_date","date":[{"dateType":"Available","dateValue":"2023-04-14"}],"displaytype":"simple","filename":"2022-os-018_論文内容要旨／論文審査結果要旨（辻野拓也）.pdf","filesize":[{"value":"332.7 kB"}],"format":"application/pdf","licensetype":"license_note","mimetype":"application/pdf","url":{"label":"論文内容要旨／論文審査結果要旨","url":"https://ompu.repo.nii.ac.jp/record/509/files/2022-os-018_論文内容要旨／論文審査結果要旨（辻野拓也）.pdf"},"version_id":"c3d72a2c-f3ad-40ca-a974-5d69858effa7"}]},"item_language":{"attribute_name":"言語","attribute_value_mlt":[{"subitem_language":"eng"}]},"item_resource_type":{"attribute_name":"資源タイプ","attribute_value_mlt":[{"resourcetype":"thesis","resourceuri":"http://purl.org/coar/resource_type/c_46ec"}]},"item_title":"RB1 loss overrides PARP inhibitor sensitivity driven by RNASEH2B loss in prostate cancer","item_titles":{"attribute_name":"タイトル","attribute_value_mlt":[{"subitem_title":"RB1 loss overrides PARP inhibitor sensitivity driven by RNASEH2B loss in prostate cancer","subitem_title_language":"en"}]},"item_type_id":"10006","owner":"19","path":["105"],"pubdate":{"attribute_name":"PubDate","attribute_value":"2023-04-14"},"publish_date":"2023-04-14","publish_status":"0","recid":"509","relation_version_is_last":true,"title":["RB1 loss overrides PARP inhibitor sensitivity driven by RNASEH2B loss in prostate cancer"],"weko_creator_id":"19","weko_shared_id":-1},"updated":"2023-11-22T06:51:29.107333+00:00"}